Developing a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in Psychosis
MANOEUVRE
MANaging emOtions in Everyday Life Using Virtual REality (MANOEUVRE): Developing a VR-assisted Intervention for Emotion Regulation Difficulties in Psychosis
1 other identifier
interventional
15
1 country
1
Brief Summary
Supporting people with psychosis to manage their emotions using virtual reality Many people who have experienced psychosis feel overwhelmed by their emotions. Emotions get in the way of doing what matters to them. They want support to manage emotions differently. There is evidence that people with psychosis find talking therapies that teach skills for managing emotions helpful. People said it helped them to understand and manage their emotions. However, they also wanted more help to apply skills they learned to their lives. It is hard to help people to use therapy skills in real-life situations. Therapists cannot be present when the skills are needed. One solution is to use virtual reality (VR) to bridge the gap between the clinic and real-life. VR involves using a headset to see and hear a very life-like computer-generated simulation of everyday life situations. People with psychosis find VR therapies engaging and helpful. It can feel safer to try things out in VR. Guided by the feedback of people with psychosis, this research will evaluate a novel therapy to help people with psychosis manage their emotions. Face-to- face therapy will be combined with VR so that people can practice emotion regulation skills safely with "live" coaching from a therapist. This should support people to use these skills when they need them. Fifteen people with psychosis will be offered the therapy. Everyone will be asked what they think of it and complete questionnaires before and after therapy to see what impact it had on their lives. A lived experience advisory group will support all aspects of the research process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2027
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2026
CompletedFirst Posted
Study publicly available on registry
June 3, 2026
CompletedStudy Start
First participant enrolled
September 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2028
Study Completion
Last participant's last visit for all outcomes
November 1, 2028
June 3, 2026
May 1, 2026
8 months
May 20, 2026
May 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difficulties in Emotion Regulation Scale 16 item version (DERS-16)
Self reported emotion regulation difficulties
Pre therapy, immediately after therapy, 3 month follow up
Other Outcomes (4)
DBT Ways of Coping Checklist - DBT Skills Subscale
Pre therapy, immediately after therapy, follow up
Clinical Outcomes in Routine Evaluation-10 item version (CORE-10)
Pre therapy, immediately after therapy, 3 month follow up
Goal Attainment Scaling (GAS)
Pre therapy, immediately after therapy, 3 month follow up
- +1 more other outcomes
Study Arms (1)
MANOEUVRE therapy
OTHERInterventions
Virtual reality assisted psychological therapy for emotion regulation difficulties
Eligibility Criteria
You may qualify if:
- Currently under the care of South London and Maudsley (SLaM) National Health Service (NHS) outpatient services.
- Clinical diagnosis of psychosis (schizophrenia spectrum disorder) (as assessed by their clinical team)
- Willing to have the interview audio recorded (if taking part in post therapy interview)
- Willing and able to provide informed consent to participate in the study (as assessed by their clinical team)
You may not qualify if:
- Clinical presentation (e.g., immediate serious risk to self) (as assessed by their clinical team)
- History of photosensitive epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London
London, Greater London, SE5 8AF, United Kingdom
Related Publications (2)
Lawlor C, Vitoratou S, Duffy J, Cooper B, De Souza T, Le Boutillier C, Carter B, Hepworth C, Jolley S. Managing emotions in psychosis: Evaluation of a brief DBT-informed skills group for individuals with psychosis in routine community services. Br J Clin Psychol. 2022 Sep;61(3):735-756. doi: 10.1111/bjc.12359. Epub 2022 Feb 7.
PMID: 35130354BACKGROUNDLawlor C, Hepworth C, Smallwood J, Carter B, Jolley S. Self-reported emotion regulation difficulties in people with psychosis compared with non-clinical controls: A systematic literature review. Clin Psychol Psychother. 2020 Mar;27(2):107-135. doi: 10.1002/cpp.2408. Epub 2020 Feb 12.
PMID: 31661593BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Professor Dame Til Wykes
King's College London
- STUDY DIRECTOR
Professor Matteo Cella
King's College London
- PRINCIPAL INVESTIGATOR
Dr Caroline Lawlor
King's College London
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2026
First Posted
June 3, 2026
Study Start (Estimated)
September 1, 2027
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
November 1, 2028
Last Updated
June 3, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- After publication
- Access Criteria
- The final anonymised study dataset will be available to other researchers at the end of the programme provided that does not compromise confidentiality.
Individual participant data that underlie the results after deidentification